{"id":"W2522288054","doi":"10.1182/blood.v126.23.3986.3986","title":"Phase 1b Study of PD-1 Blockade with Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Population; Phases of clinical research; Cohort; Clinical trial; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001825991,0.001419935,0.001522067,0.0003266929,0.0003998108,0.0008784357,0.0007526973,0.001135713,0.003005957],"category_scores_gemma":[0.0007659824,0.0005900901,0.0009634221,0.0003884553,0.0007021737,0.0007243704,0.0003818412,0.003087387,0.001045353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009037413,"about_ca_system_score_gemma":0.001371886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007859268,"about_ca_topic_score_gemma":0.00146018,"domain_scores_codex":[0.9995993,0.0001908888,0.00002171156,0.00006741987,0.0000382716,0.00008246036],"domain_scores_gemma":[0.9994817,0.00007837094,0.00007497352,0.00004983518,0.00003794689,0.0002772498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5936055,0.1444374,0.02221661,0.001187,0.001808584,0.0007269506,0.0005867008,0.003665438,0.1022649,0.0003893774,0.006202129,0.1229093],"study_design_scores_gemma":[0.4877034,0.4772099,0.02440687,0.00003951569,0.0004488212,0.0005529141,0.00007051383,0.00119652,0.005509329,0.0001866255,0.00265065,0.00002485674],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936992,0.001333289,0.0003986553,0.0003725829,0.00006036742,0.001983206,0.0009306339,0.00006497183,0.00115693],"genre_scores_gemma":[0.9920557,0.000861824,0.001102757,0.0005499037,0.0001057178,0.002063622,0.002013439,0.00001785061,0.001229148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003005957,"threshold_uncertainty_score":0.0100559,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01103516363985492,"score_gpt":0.235695526364517,"score_spread":0.2246603627246621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}